April 26, 2018 Gamida Cell Strengthens Leadership Team with Appointments of Josh Hamermesh as Chief Business Officer and Paul Nee as Vice President of Marketing View Article
April 10, 2018 MYLAN TO ACQUIRE THE GLOBAL MARKETING RIGHTS TO A ONCE-MONTHLY GLATIRAMER ACETATE PRODUCT THROUGH AN INVESTMENT AND PARTNERSHIP WITH ISRAELI COMPANY MAPI PHARMA View Article
March 12, 2018 Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson’s Disease View Article
February 7, 2018 Kamada Exceeds 2017 Revenue Guidance of $100M and Becomes Cash Flow Positive On February 7th, View Article
January 31, 2018 Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer View Article
January 30, 2018 First Patient Treated in Mapi Pharma’s Phase II Clinical Trial of GA Depot for Primary Progressive Multiple Sclerosis (PPMS) View Article
January 30, 2018 Gamida Recruiting Lymphoma Patients for Phase 1 Trial of Natural Killer Cell Therapy View Article
